Mike Fink
About Mike Fink
Mike Fink is a Senior Scientist with extensive experience in the pharmaceutical industry, having worked at notable companies such as Merck, Schering-Plough Research Institute, Celgene, Tris Pharma, and currently at Insmed Incorporated.
Work at Insmed
Mike Fink has been employed at Insmed Incorporated as a Senior Scientist since 2019. His role involves conducting research and development activities aimed at advancing the company's therapeutic programs. Insmed focuses on innovative treatments for serious diseases, and Fink's contributions are integral to the company's research initiatives in Bridgewater, NJ.
Previous Experience at Celgene
Before joining Insmed, Mike Fink worked as a Scientist (Contractor) at Celgene from 2014 to 2015. During his one-year tenure in Summit, he contributed to various projects within the organization, which is known for its focus on developing therapies for cancer and immune-inflammatory diseases.
Experience at Tris Pharma
Mike Fink served as a Senior Scientist at Tris Pharma from 2015 to 2018. Over three years in Monmouth Junction, he engaged in the development of pharmaceutical products, focusing on innovative drug delivery systems that enhance patient outcomes.
Career at Merck
Mike Fink worked as a Scientist at Merck from 2009 to 2013. His four-year experience at this global healthcare company involved various research projects aimed at discovering and developing new medications across multiple therapeutic areas.
Tenure at Schering-Plough Research Institute
Mike Fink's career includes eight years as a Scientist at Schering-Plough Research Institute from 2001 to 2009. His work there contributed to significant advancements in pharmaceutical research and development before the company was acquired by Merck.